ARSA Gene Metachromatic Leukodystrophy Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين ARSA للحثل المادة البيضاء متبدل اللون (MLD) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary – ARSA NGS Analysis at DNA Labs UAE

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-accredited NGS, validated against 2026 AI-curated variant databases.
Premium Logistics: Paid hospital-grade home collection with ISO-certified cold-chain transport (8 AM – 11 PM) and VIP mobile phlebotomy.
Clinical Guidance: Complimentary telephonic post-test clinical guidance with a DHA-licensed physician for result interpretation.
Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.

ملخص تنفيذي: يُقدّم مختبر DNA الإمارات تحليلًا جينيًا متطورًا لجين ARSA المسؤول عن مرض الحثل المادة البيضاء متبدل اللون (MLD) باستخدام تقنية التسلسل الجيني من الجيل التالي (NGS) بدقة تشخيصية تصل إلى 99.9%. تشمل الخدمة استشارة وراثية قبل الاختبار، سحب منزلي معتمد، نقل مبرّد وفق معايير ISO، وتوجيه طبي هاتفي بعد النتيجة. جميع الإجراءات متوافقة مع قانون دولة الإمارات العربية المتحدة لحماية البيانات الشخصية (PDPL) ومعايير هيئة الصحة بدبي.

Understanding the ARSA Gene & Metachromatic Leukodystrophy (MLD)

The ARSA NGS test screens the entire coding region of the arylsulfatase A gene for pathogenic variants linked to MLD, a rare autosomal recessive lysosomal storage disorder. يقوم التحليل بفحص شامل للجين ARSA لتحديد الطفرات المسببة لمرض الحثل المادة البيضاء متبدل اللون، والذي يؤثر على الجهاز العصبي.

Feature	Our NGS Test (DNA Labs UAE)	Closest Alternative (Single-Gene Sanger)
Precision	Full gene sequencing & copy number analysis; >99.9% sensitivity for point mutations and indels	Targeted exon-by-exon; may miss deep intronic or large deletions/duplications
Methodology	NGS with Illumina platform, bioinformatics pipeline aligned to 2026 genomic standards (GRCh38)	Conventional Sanger sequencing
Turnaround	3–4 weeks, with expedited option on medical urgency	6–8 weeks

Physician Insight & Safety Protocol

“The ARSA genetic test offers profound insight but must always be interpreted in the context of clinical presentation, biochemical markers, and family history. I strongly recommend pre-test genetic counseling to prepare families for the implications of positive, negative, or uncertain results. A positive result does not automatically mean a severe phenotype; correlation with arylsulfatase A enzyme activity and imaging is essential.”

— Dr. PRABHAKAR REDDY, DHA License: 61713011

Medication Warning

Do not discontinue any prescribed medication or therapy without consulting your treating physician. Genetic results are informational and must not be used as sole justification to alter treatment plans.

Exclusion Criteria & Emergency Red Flags

Patients who are unable or unwilling to provide informed consent or a valid clinical history.
Individuals under 18 years without legal guardian consent (as per UAE CDS Law 2026).
Emergency signs needing immediate care: acute neurological deterioration, loss of consciousness, new‑onset seizures, or severe respiratory distress – do not delay emergency care for this test.

Patient FAQ & Clinical Guidance

1. How accurate is this ARSA NGS test for diagnosing metachromatic leukodystrophy?

Our test offers 99.9% diagnostic sensitivity for ARSA gene mutations when complemented by enzyme analysis and clinical assessment. NGS covers all coding exons, splice sites, and known copy number variations associated with MLD. However, a negative result does not completely exclude the disease if biochemical findings are abnormal; further investigation may be needed. Every result is reviewed by a DHA‑licensed physician and genetic counselor.

2. What sample types can be used, and is home collection available in the UAE?

We accept whole blood, extracted DNA, or a simple dried blood spot on an FTA card, all collected at your convenience. Our hospital‑grade home collection service, available daily 8 AM–11 PM, ensures cold‑chain integrity; a phlebotomist arrives with ISO‑certified kits. FTA cards are ideal for paediatric patients or remote locations. You will receive detailed pre‑ instructions and a genetic counseling session prior to sampling.

3. هل يتطلب الاختبار صيامًا أو إيقاف الأدوية؟ وماذا عن الاستشارة الوراثية؟

لا يتطلب تحليل جين ARSA أي صيام أو تغيير في الأدوية؛ ننصح بمواصلة العلاج كما وصفه الطبيب. قبل سحب العينة، يلزم عقد جلسة استشارة وراثية لرسم شجرة العائلة وتحديد الأفراد المصابين أو حاملي المرض. الاستشارة تساعد في تفسير النتيجة وتخطيط الرعاية المستقبلية. يُرجى التواصل عبر واتساب على +971545488731 لحجز موعد الاستشارة.

Regulatory Compliance: This service adheres to Federal Decree-Law No. 41 of 2024 (Art. 87), UAE CDS Law 2026 for minors, and UAE PDPL. Facility License: 9834453. ISO 9001:2015 Certified – Cert: INT/EGQ/2509DA/3139.

Clinical Supervision: Reviewed by Dr. PRABHAKAR REDDY, DHA License 61713011. Clinical guidance is provided via telephonic consultation post‑result.

دعم ثنائي اللغة متاح